Literature DB >> 3122789

Anti-HIV IgM antibody analysis during early manifestations of HIV infections.

H I Joller-Jemelka1, P W Joller, F Müller, J Schüpbach, P J Grob.   

Abstract

In a prospective study we tested the appearance of IgG and IgM positive viral protein bands in Western blots from six people who seroconverted for anti-HIV antibody. Quantification of the immunoblotted bands was performed by reading the Western blot stripes in Camag scanner and analysed on a 350 computer (digital equipment). In the first serum, all people were negative for anti-HIV antibodies. In the second serum, after 16 to 122 days, all people showed IgM HIV-antibodies to p24. IgG HIV-antibodies were detectable in all people after 18 to 114 days after the second collection. Our data clearly demonstrated that for early analysis of HIV infection only the detection of IgM antibodies to viral protein bands of the Western blot technique provides reliable results and that scanning and advanced integration analysis of the Western blot peaks offer the advantage of direct quantitative comparison of the results, not just qualitative description. Further, this direct quantitative comparison of antibodies to HIV virus protein bands can be used as a prognostic marker for disease states.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122789

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.

Authors:  G Schmidt; K Amiraian; H Frey; J Wethers; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Authors:  J Mahony; K Rosenthal; M Chernesky; S Castriciano; E Scheid; M Blajchman; D Harnish
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

4.  Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.

Authors:  H Pollack; M X Zhan; T Ilmet-Moore; K Ajuang-Simbiri; K Krasinski; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  Detection of anti-HIV-1 immunoglobulin M antibodies in patients with serologically proved HIV-1 infection.

Authors:  F Müller; K H Müller
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

Review 6.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  Serological response in patients with chronic asymptomatic human immunodeficiency virus infection.

Authors:  B O Lindhardt; K Ulrich; P Kusk; B Hofmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.